Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 70-79 , March 2008

Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA Study

  • Narayanan I. Valappil, PhD, MPH

      Affiliations

    • Health Resources and Services Administration, Rockville, Maryland, USA
    • ,
  • David R. Jacobs Jr, PhD

      Affiliations

    • Division of Epidemiology, School of Public Health University of Minnesota, Minneapolis, Minnesota, USA and Department of Nutrition, University of Oslo, Oslo, Norway
    • Corresponding Author InformationCorresponding author: David R. Jacobs, Jr, PhD, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, Minnesota 55454. Tel: 612-624-4196; fax: 612-624-0315.
    • ,
  • Daniel A. Duprez, MD, PhD

      Affiliations

    • Cardiovascular Division, Medical School, University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • Myron D. Gross, PhD

      Affiliations

    • Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • Donna K. Arnett, PhD

      Affiliations

    • Department of Epidemiology, UAB School of Public Health, Birmingham, Alabama, USA
    • ,
  • Stephen Glasser, MD

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA

Received 31 May 2007 ,Accepted 2 October 2007.

References 

  1. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens. 2005;19:515–519
  2. Cobb FR, Kraus WE, Root M, Allen JD. Assessing risk for coronary heart disease: beyond Framingham. Am Heart J. 2003;146:679–685
  3. Duprez DA, Cohn JN. Monitoring vascular health beyond blood pressure. Curr Hypertens Rep. 2006;8:287–291
  4. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular disease. Hypertension. 2003;107:2864–2869
  5. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weakness. J Hypertens. 2003;21:463–472
  6. McVeigh GE. Pulse waveform analysis and arterial wall properties. Hypertension. 2003;41:1010–1011
  7. O’Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness, definitions, and reference values. Am J Hyperten. 2002;15:426–444
  8. Duprez DA, Kaiser DR, Whitwam W, Finkelstein S, Belalcazar A, Patterson R, et al. Determinants of radial artery pulse wave analysis in asymptomatic individuals. Am J Hypertens. 2004;17:647–653
  9. Finkelstein SM, Cohn JN. First- and third-order models for determining arterial compliance. J Hypertens Suppl. 1992;10:S11–S14
  10. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–1160
  11. Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz P, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 1989;80:458–465
  12. Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92:395–399
  13. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105–1116
  14. Gross M, Yu X, Hannan P, Prouty C, Jacobs DR. Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA Study. Am J Clin Nutr. 2003;77:458–466
  15. Warnick G. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 1986;129:101–123
  16. Warnick G, Benderson J, Albers J. Dextran sulphate -Mg2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379–1388
  17. Friedewald WT, Levy RI, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  18. Jacobs DR, Murtaugh M, Steffes M, Yu X, Roseman J, Goetz F. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol. 2002;155:1114–1119
  19. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930–937
  20. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension. 1995;26:503–508
  21. Murtaugh MA, Jacobs DR, Yu X, Gross MD, Steffes M. Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol. 2003;158:676–686
  22. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage (The Steno hypothesis). Diabetologia. 1989;32:219–226
  23. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens. 2004;17:986–993
  24. Marschang P, Friedrich GJ, Ditlbacher H, Stoeger A, Nedden DZ, Kirchmair R, et al. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol. 2006;106:183–190
  25. Demerath E, Towne B, Blangero J, Siervogel RM. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol. 2001;28:664–678
  26. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426
  27. Beamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic stroke. Arch Neurol. 1999;56:699–702
  28. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93:71–81
  29. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn study. Arterioscler Thromb Vasc Biol. 1999;19:617–624
  30. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion (An independent predictor of ischemic heart disease). Arterioscler Thromb Vasc Biol. 1999;19:1992–1997
  31. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria (Potential marker for increased cardiovascular risk factors in nondiabetic subjects?). Arteriosclerosis. 1990;10:727–731
  32. de Simone G, Roman MJ, Koren MJ, Mensah GA, Ganau A, Devereux RB. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension. 1999;33:800–805
  33. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117
  34. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  35. Safar ME, Henry O, Meaume S. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Geriatr Cardiol. 2002;11:295–298
  36. Bhuiyan AR, Li S, Li H, Chen W, Srinivasan SR, Berenson GS. Distribution and correlates of arterial compliance measures in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens. 2005;18:684–691
  37. Bhuiyan AR, Srinivasan SR, Chen W, Paul TK, Berenson GS. Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis. 2006;189:1–7
  38. Dart AM, Gatzka CD, Cameron JD, Kingwell BA, Liang YL, Berry KL, et al. Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol. 2004;24:962–968
  39. Arnett DK, Glasser SP, McVeigh G, Prineas R, Finklestein S, Donahue R, et al. Blood pressure and arterial compliance in young adults: the Minnesota children’s blood pressure study. Am J Hypertens. 2001;14:200–205
  40. McVeigh GE, Morgan DJ, Finkelstein SM, Lemay LA, Cohn JN. Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis. Am J Med. 1997;102:227–231
  41. Jacobs DR, Crow RS. Subclinical cardiovascular disease markers applicable to studies of oral health: multiethnic study of atherosclerosis. Ann NY Acad Sci. 2007;1098:269–287
  42. Manning TS, Shykoff BE, Izzo JL. Validity and reliability of diastolic pulse contour analysis (Windkessel model) in humans. Hypertension. 2002;39:963–968
  43. Rietzschel ER, Boeykens E, De Buyzere ML, Duprez DA, Clement DL. A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension. 2001;37:E15–E22
  44. Cohn JN. Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease. Prog Cardiovasc Dis. 1999;41:441–450
  45. Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Rizzoni D, et al. Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: reliability, repeatability, and establishment of normal values for healthy European population—the Seven European Sites Study (SESS). Am J Hypertension. 2005;18:65–71

 The CARDIA study is supported by contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and N01-HC-95095 from the National Heart, Lung, and Blood Institute. The YALTA study is supported by R01 HL 53560.

 Conflict of interest: none.

PII: S1933-1711(07)00201-X

doi: 10.1016/j.jash.2007.10.002

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 70-79 , March 2008

Article Tools

* Image Usage & Resolution